Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2016

Open Access 01-12-2016 | Research article

Clinicopathological features and prognosis of gastric cancer in young patients

Authors: Shushang Liu, Fan Feng, Guanghui Xu, Zhen Liu, Yangzi Tian, Man Guo, Xiao Lian, Lei Cai, Daiming Fan, Hongwei Zhang

Published in: BMC Cancer | Issue 1/2016

Login to get access

Abstract

Background

The clinicopathological features and prognosis of gastric cancer in young patients are both limited and controversial. Therefore, the aim of this study was to define the clinicopathological features and prognosis of gastric cancer in young patients after curative resection.

Methods

From May 2008 to December 2014, 198 young patients (age ≤ 40 years) and 1096 middle-aged patients (55 ≤ age ≤ 64 years) were enrolled in this study. The clinicopathological features and prognosis of gastric cancer in these patients were analyzed.

Results

Compared with middle-aged patients, the proportion of females, lower third tumors, tumor size less than 5 cm, poorly differentiated tumors and T1 tumors were significantly higher in young patients (all P < 0.05). The proportions of comorbidity, upper third tumors, well and moderately differentiated tumors, T4 tumors, and positive carcinoembryonic antigen (CEA), alpha fetoprotein (AFP) and carbohydrate antigen (CA) 19–9 were significantly lower in young patients (all P < 0.05). The distributions of N status and CA125 were comparable between young and middle-aged patients (all P > 0.05). The five-year overall survival rates were comparable between young patients and middle-aged patients (62.8 vs 54.7 %, P = 0.307). The tumor location, T status, N status and CA125 were independent predictors of prognosis in young patients. The overall survival of patients with tumors located in the upper or middle third was significantly lower than for those located in the lower third (60.8 vs 50.6 % vs 68.4 %, P = 0.016). The overall survival of CA125-positive patients was significantly lower than CA125-negative patients (49.0 vs 64.4 %, P = 0.001).

Conclusion

The clinicopathological features were significantly different between young and middle-aged patients. The prognosis of gastric cancer in young patients was equivalent to that of middle-aged patients. Tumor location, T status, N status and CA125 were independent risk factors for prognosis in young patients.
Appendix
Available only for authorised users
Literature
1.
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.CrossRefPubMed
2.
Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA: A Cancer Journal for Clinicians. 2016;66(2):115–32.
3.
Anderson WF, Camargo MC, Fraumeni JJ, Correa P, Rosenberg PS, Rabkin CS. Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA. 2010;303(17):1723–8.CrossRefPubMedPubMedCentral
4.
Kuller LH. Age-adjusted death rates: a hazard to epidemiology? Ann Epidemiol. 1999;9(2):91–2.PubMed
5.
Takatsu Y, Hiki N, Nunobe S, Ohashi M, Honda M, Yamaguchi T, et al. Clinicopathological features of gastric cancer in young patients. Gastric Cancer. 2015;19(2):472–8.
6.
Hsieh F, Wang Y, Hsu J, Liu K, Yeh C, Yeh T, et al. Clinicopathological features and prognostic factors of gastric cancer patients aged 40 years or younger. J Surg Oncol. 2012;105(3):304–9.CrossRefPubMed
7.
Saito H, Takaya S, Fukumoto Y, Osaki T, Tatebe S, Ikeguchi M. Clinicopathologic characteristics and prognosis of gastric cancer in young patients. Yonago Acta Med. 2012;55(3):57–61.PubMedPubMedCentral
8.
Santoro R, Carboni F, Lepiane P, Ettorre GM, Santoro E. Clinicopathological features and prognosis of gastric cancer in young European adults. Br J Surg. 2007;94(6):737–42.CrossRefPubMed
9.
KUNISAKI C, AKIYAMA H, NOMURA M, MATSUDA G, OTSUKA Y, ONO H, et al. Clinicopathological Features of Gastric Carcinoma in Younger and Middle-Aged Patients: A Comparative Study. J Gastrointest Surg. 2006;10(7):1023–32.CrossRefPubMed
10.
Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471–4.CrossRefPubMed
11.
Kojima O, Takahashi T, Kawakami S, Uehara Y, Matsui M. Localization of estrogen receptors in gastric cancer using immunohistochemical staining of monoclonal antibody. Cancer. 1991;67(9):2401–6.CrossRefPubMed
12.
Jaspers VK, Gillessen A, Quakernack K. Gastric cancer in pregnancy: do pregnancy, age or female sex alter the prognosis? Case reports and review. Eur J Obstet Gynecol Reprod Biol. 1999;87(1):13–22.CrossRefPubMed
13.
Matsui M, Kojima O, Kawakami S, Uehara Y, Takahashi T. The prognosis of patients with gastric cancer possessing sex hormone receptors. Surg Today. 1992;22(5):421–5.CrossRefPubMed
14.
Kath R, Fiehler J, Schneider CP, Hoffken K. Gastric cancer in very young adults: apropos four patients and a review of the literature. J Cancer Res Clin Oncol. 2000;126(4):233–7.CrossRefPubMed
15.
Lee JH, Ryu KW, Lee JS, Lee JR, Kim CG, Choi IJ, et al. Decisions for extent of gastric surgery in gastric cancer patients: younger patients require more attention than the elderly. J Surg Oncol. 2007;95(6):485–90.CrossRefPubMed
16.
Haruma K, Komoto K, Kamada T, Ito M, Kitadai Y, Yoshihara M, et al. Helicobacter pylori infection is a major risk factor for gastric carcinoma in young patients. Scand J Gastroenterol. 2000;35(3):255–9.CrossRefPubMed
17.
Hirahashi M, Yao T, Matsumoto T, Nishiyama K, Oya M, Iida M, et al. Intramucosal gastric adenocarcinoma of poorly differentiated type in the young is characterized by Helicobacter pylori infection and antral lymphoid hyperplasia. Mod Pathol. 2007;20(1):29–34.CrossRefPubMed
18.
Rotterdam H. Pathology of the gastric cardia. Verh Dtsch Ges Pathol. 1999;83:37–42.PubMed
19.
Yagi K, Nakamura A, Sekine A, Oyamatsu M, Tamiya Y, Watanabe H. An early cancer of the gastric cardia arising from carditis after long-term gastroesophageal reflux disease in the absence of Helicobacter pylori infection. J Gastroenterol Hepatol. 2002;17(11):1236–8.CrossRefPubMed
20.
21.
Heading RC. Review article: diagnosis and clinical investigation of gastro-oesophageal reflux disease: a European view. Aliment Pharmacol Ther. 2004;20 Suppl 8:9–13.CrossRefPubMed
22.
Imagama S, Hasegawa Y, Wakao N, Hirano K, Hamajima N, Ishiguro N. Influence of lumbar kyphosis and back muscle strength on the symptoms of gastroesophageal reflux disease in middle-aged and elderly people. Eur Spine J. 2012;21(11):2149–57.CrossRefPubMedPubMedCentral
23.
Qiu M, Wang Z, Zhang D, Luo H, Zhou Z, Wang F, et al. Clinicopathological characteristics and prognostic analysis of gastric cancer in the young adult in China. Tumor Biol. 2011;32(3):509–14.CrossRef
24.
Zhou Y, Zhao H, Shen L. Preoperative Serum CEA and CA19-9 in Gastric Cancer - a Single Tertiary Hospital Study of 1,075 Cases. Asian Pac J Cancer Prev. 2015;16(7):2685–91.CrossRefPubMed
25.
Chao A, Tang Y, Lai C, Chang C, Chang S, Wu T, et al. Potential of an age-stratified CA125 cut-off value to improve the prognostic classification of patients with endometrial cancer. Gynecol Oncol. 2013;129(3):500–4.CrossRefPubMed
26.
Sun Z, Zhang N. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy. World J Surg Oncol. 2014;12:397.CrossRefPubMedPubMedCentral
27.
Chen Y, Qu H, Jian M, Sun G, He Q. High level of serum AFP is an independent negative prognostic factor in gastric cancer. Int J Biol Markers. 2015;30(4).
28.
Wang D, Li C, Xu Y, Xing Y, Qu L, Guo Y, et al. Clinicopathological characteristics and prognosis of alpha-fetoprotein positive gastric cancer in Chinese patients. Int J Clin Exp Pathol. 2015;8(6):6345–55.PubMedPubMedCentral
29.
30.
Tian S, Yu J, Kang W, Ma Z, Ye X, Cao Z, et al. Combined Detection of CEA, CA 19–9, CA 242 and CA 50 in the Diagnosis and Prognosis of Resectable Gastric Cancer. Asian Pac J Cancer Prev. 2014;15(15):6295–300.CrossRefPubMed
31.
He CZ, Zhang KH, Li Q, Liu XH, Hong Y, Lv NH. Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer. BMC Gastroenterol. 2013;13:87.CrossRefPubMedPubMedCentral
32.
Silva EM, Begnami MD, Fregnani JHTG, Pelosof AG, Zitron C, Montagnini AL, et al. Cadherin-catenin adhesion system and mucin expression: a comparison between young and older patients with gastric carcinoma. Gastric Cancer. 2008;11(3):149–59.CrossRefPubMed
33.
Llanos O, Butte JM, Crovari F, Duarte I, Guzmán S. Survival of Young Patients after Gastrectomy for Gastric Cancer. World J Surg. 2006;30(1):17–20.CrossRefPubMed
34.
Liu K, Zhang W, Chen X, Chen X, Yang K, Zhang B, et al. Comparison on Clinicopathological Features and Prognosis Between Esophagogastric Junctional Adenocarcinoma (Siewert II/III Types) and Distal Gastric Adenocarcinoma. Medicine. 2015;94(34):e1386.CrossRefPubMedPubMedCentral
35.
Tocchi A, Costa G, Lepre L, Liotta G, Mazzoni G, Cianetti A, et al. The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer. J Cancer Res Clin Oncol. 1998;124(8):450–5.CrossRefPubMed
Metadata
Title
Clinicopathological features and prognosis of gastric cancer in young patients
Authors
Shushang Liu
Fan Feng
Guanghui Xu
Zhen Liu
Yangzi Tian
Man Guo
Xiao Lian
Lei Cai
Daiming Fan
Hongwei Zhang
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2016
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-016-2489-5

Other articles of this Issue 1/2016

BMC Cancer 1/2016 Go to the issue

Study protocol

Effectiveness of a multimodal standard nursing program on health-related quality of life in Chinese mainland female patients with breast cancer: protocol for a single-blind cluster randomized controlled trial

Case report

Paraneoplastic lipase and amylase production in a patient with small-cell lung cancer: case report

Case report

Herpes simplex virus-1 encephalitis induced by chemoradiotherapy and steroids in an esophageal cancer patient: a case report

Research article

Comparison of the pharmacokinetics between L-BPA and L-FBPA using the same administration dose and protocol: a validation study for the theranostic approach using [18F]-L-FBPA positron emission tomography in boron neutron capture therapy

Research article

Distribution and prognosis of uncommon metastases from non-small cell lung cancer

Research article

In vitro and in vivo activity of miR-92a–Locked Nucleic Acid (LNA)–Inhibitor against endometrial cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits